In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $40.65 down -1.38% from its previous closing price of $41.22. In other words, the price has decreased by -$1.38 from its previous closing price. On the day, 0.51 million shares were traded. KYMR stock price reached its highest trading level at $41.5 during the session, while it also had its lowest trading level at $39.655.
Ratios:
For a deeper understanding of Kymera Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.55 and its Current Ratio is at 8.55. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $55.
Wells Fargo Upgraded its Equal Weight to Overweight on December 02, 2024, while the target price for the stock was maintained at $57.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 06 ’25 when Chiniara Ellen sold 3,129 shares for $41.75 per share. The transaction valued at 130,645 led to the insider holds 54,826 shares of the business.
Chiniara Ellen bought 3,129 shares of KYMR for $130,135 on Jan 06 ’25. On Dec 02 ’24, another insider, Esposito Pamela, who serves as the Director of the company, sold 2,500 shares for $49.00 each. As a result, the insider received 122,500 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 2632709632 and an Enterprise Value of 2170969344. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.07 while its Price-to-Book (P/B) ratio in mrq is 2.95. Its current Enterprise Value per Revenue stands at 24.793 whereas that against EBITDA is -11.397.
Stock Price History:
The Beta on a monthly basis for KYMR is 2.20, which has changed by 0.25747406 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $29.24. The 50-Day Moving Average of the stock is -5.03%, while the 200-Day Moving Average is calculated to be -2.10%.
Shares Statistics:
For the past three months, KYMR has traded an average of 481.65K shares per day and 583600 over the past ten days. A total of 64.75M shares are outstanding, with a floating share count of 54.99M. Insiders hold about 15.09% of the company’s shares, while institutions hold 93.63% stake in the company. Shares short for KYMR as of 1736899200 were 8352487 with a Short Ratio of 17.34, compared to 1734048000 on 8794125. Therefore, it implies a Short% of Shares Outstanding of 8352487 and a Short% of Float of 14.399999999999999.
